Retreatment of interferon relapse patients with chronic hepatitis C

被引：6

作者：

Buti, M ^{[1
]}

Esteban, R ^{[1
]}

机构：

[1] Hosp Gen Univ Valle Hebron, Barcelona, Spain

来源：

JOURNAL OF HEPATOLOGY | 1999年 / 31卷

关键词：

D O I：

10.1016/S0168-8278(99)80396-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：174 / 177

页数：4

共 11 条

[1] Therapy of hepatitis C: Re-treatment with alpha interferon
Alberti, A
Chemello, L
Noventa, F
Cavalletto, L
DeSalvo, G
[J]. HEPATOLOGY, 1997, 26 (03) : S137 - S142
[2] Re-treatment with interferon alfa of patients with chronic hepatitis C
Chow, WC
Boyer, N
Pouteau, M
Castelnau, C
Martinot-Peignoux, M
Martins-Amado, V
Degos, F
Maghinici, C
Sinegre, M
Benhamou, JP
Degott, C
Erlinger, S
Marcellin, P
[J]. HEPATOLOGY, 1998, 27 (04) : 1144 - 1148
[3] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
Davis, GL
Esteban-Mur, R
Rustgi, V
Hoefs, J
Gordon, SC
Trepo, C
Shiffman, ML
Zeuzem, S
Craxi, A
Ling, MH
Albrecht, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) : 1493 - 1499
[4] Re-treatment of chronic hepatitis C with consensus interferon
Heathcote, EJL
Keeffe, EB
Lee, SS
Feinman, SV
Tong, MJ
Reddy, KR
Albert, DG
Witt, K
Blatt, LM
[J]. HEPATOLOGY, 1998, 27 (04) : 1136 - 1143
[5] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
McHutchison, JG
Gordon, SC
Schiff, ER
Shiffman, ML
Lee, WM
Rustgi, VK
Goodman, ZD
Ling, MH
Cort, S
Albrecht, JK
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) : 1485 - 1492
[6] Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial
Payen, JL
Izopet, J
Galindo-Migeot, V
Lauwers-Cances, V
Zarski, JP
Seigneurin, JM
Dussaix, E
Voigt, JJ
Selves, J
Barange, K
Puel, J
Pascal, JP
[J]. HEPATOLOGY, 1998, 28 (06) : 1680 - 1686
[7] Picciotto A., 1996, Hepatology, V24, p273A
[8] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Poynard, T
Marcellin, P
Lee, SS
Niederau, C
Minuk, GS
Ideo, G
Bain, V
Heathcote, J
Zeuzem, S
Trepo, C
Albrecht, J
[J]. LANCET, 1998, 352 (9138) : 1426 - 1432
[9] LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH ALPHA-INTERFERON
SHINDO, M
DIBISCEGLIE, AM
HOOFNAGLE, JH
[J]. HEPATOLOGY, 1992, 15 (06) : 1013 - 1016
[10] TOYODA H, 1994, AM J GASTROENTEROL, V89, P1453

← 1 2 →